MedTrace Logo

Dapsone Prurigo Study

NCT01870050 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-06-05

No results posted yet for this study

Summary

Principal aim of this study is to assess whether a combination of topical dapsone and clobetasol as a topical steroid is superior to clobetasol alone as treatment of prurigo nodularis or lichen simplex chronicus in a side to side comparison. The study is primarily exploratory and essentially meant to inform the sponsor whether further development of a combination treatment formulation is warranted

Conditions

  • Lichen Simples Chronicus and Prurigo

Interventions

DRUG

Dapsone gel - verum

Sponsors & Collaborators

  • Cook County Health

    lead OTHER_GOV

Principal Investigators

  • Joerg Albrecht, MD · J.H.Stroger Hospital of Cook County

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01870050 on ClinicalTrials.gov